최신 재무제표(Form-10K)에 따르면, Procyon Corp의 총 자산은 $0이며, 순손실입니다.
PCYN의 주요 재무 비율은 무엇인가요?
Procyon Corp의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Procyon Corp의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
현재 Procyon Corp 데이터는 사용할 수 없습니다.
Procyon Corp은 수익성이 있나요?
no, 최신 재무제표에 따르면 Procyon Corp의 순손실은 $0입니다.
Procyon Corp에 부채가 있나요?
no, Procyon Corp의 부채는 0입니다.
Procyon Corp의 발행 주식은 몇 주인가요?
Procyon Corp의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$0.201
시가
$0.201
일일 범위
$0.201 - $0.201
52주 범위
$0.0013 - $0.28
거래량
10.0K
평균 거래량
380
배당수익률
--
EPS(TTM)
-0.04
시가총액
$1.6M
PCYN란 무엇인가요?
Procyon Corp. is a holding company, which engages in the development and marketing of skin and wound care products. The company is headquartered in Clearwater, Florida and currently employs 19 full-time employees. AMERX develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. The company provides skin and wound care products through its proprietary brands, AMERIGEL Advanced Skin and Wound Care, HELIX3 Bioactive Collagen, and EXTREMIT-EASE compresson Garment. Its AMERIGEL products are made with Oakin, that promote healing in wounds and problematic skin conditions while fighting infection, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its kits and dressings products include AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Thin Hydrocolloid Dressings, and AMERX Wound Care Kits.